Skip to content
Research Article Peer ReviewedAt least two reviewers Open Access

Heparinin İndüklediği Trombositopeni: Olgu sunumu

1Hitit University
✉ Corresponding author: Alperen Kısa · alperenkisa@hotmail.com.tr
PDF BibTeX RIS

Abstract

Heparinin indüklediği trombositopeni (HİT), heparin kullanımı sonrası immünolojik mekanizmalar yoluyla gelişen, arteriyel ve venöz tromboembolizm ile karakterize katastrofik  nadir görülen bir komplikasyondur. heparin kullanımını takiben genellikle 5-14. günlerde gelişir. HİT geliştiğinde heparin tedavisi kesilmeli ve direkt trombin inhibitörleri başlanmalıdır.Bu yazıda HİT’ye bağlı tromboembolik komplikasyonlar gelişen bir olgu sunarak nadir görülen bu komplikasyona farkındalık oluşturmayı amaçladık.

English-language details

Heparin-Induced Thrombocytopenia: Case Report

Heparin-induced thrombocytopenia (HIT) is a catastrophic, rare complication characterized by arterial and venous thromboembolism that develops via immunological mechanisms following heparin use. It usually develops 5-14 days after heparin administration. When HIT develops, heparin treatment should be discontinued and direct thrombin inhibitors should be initiated. In this article, we aim to raise awareness of this rare complication by presenting a case of thromboembolic complications that developed due to HIT.

Keywords

Cite this article

Kısa, A. (2019). Heparin-Induced Thrombocytopenia: Case Report. In 4th International Symposium on Innovative Approaches in Health and Sports Sciences (pp. 115–117). SET Technology. https://doi.org/10.36287/setsci.4.9.076

Article History

Published
23 Dec 2019

License

© 2019 SET Technology. This article is distributed under the terms of the CC BY 4.0.

Research Contributions (2019+)Peer reviewed by at least two reviewers
Open AccessCC BY 4.0
Open Discovery Metadata · DOI · OAI-PMH
Global Reachresearchers worldwide